drug-eluting balloon

Emerging technologies: polymer-free phospholipid encapsulated sirolimus nanocarriers for the controlled release of drug from a stent-plus-balloon or a stand-alone balloon catheter

• Lemos P,
• Farooq V,
• Takimura C,
• Gutierrez P,
• Virmani R,
• Kolodgie F,
• Christians U,
• Kharlamov A,
• Doshi M,
• Sojitra P,
• van Beusekom H,
• Serruys PW

EuroIntervention 2013;9:148-156

Published in Volume 9 Number 1, May 2013

Comparison of two drug-eluting balloons: a report from the SCAAR registry

• Bondesson P,
• Lagerqvist B,
• James S,
• Olivecrona G,
• Venetsanos D,
• Harnek J

EuroIntervention 2012;8:444-449

Published in Volume 8 Number 4, August 2012

Vascular effects of paclitaxel following drug-eluting balloon angioplasty in a porcine coronary model: the importance of excipient

• Radke P,
• Joner M,
• Joost A,
• Byrne R,
• Hartwig S,
• Bayer G,
• Steigerwald K,
• Wittchow E

EuroIntervention 2011;7:730-737

Published in Volume 7 Number 6, October 2011

Description of Pantera Lux paclitaxel-releasing balloon and preliminary quantitative coronary angiography (QCA) results at six months in patients with coronary in-stent restenosis

• Hehrlein C,
• Richardt G,
• Wiemer M,
• Schneider H,
• Naber C,
• Hoffmann E,
• Dietz U

EuroIntervention 2011;7:K119-K124

Published in Volume 7 Supplement K, May 2011

Drug-eluting balloons: future potential indications and applications

• Choo G-H

EuroIntervention 2011;7:K112-K118

Published in Volume 7 Supplement K, May 2011

Antiplatelet therapy in the era of percutaneous coronary intervention with drug-eluting balloons

• Bonaventura K,
• Sonntag S-M,
• Kleber F-X

EuroIntervention 2011;7:K106-K111

Published in Volume 7 Supplement K, May 2011

Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study

• Adrianssens T,
• Dens J,
• Ughi G,
• Coosemans M,
• Onsea K,
• Dubois C,
• Sinnaeve P,
• Vrolix M,
• Desmet W

EuroIntervention 2011;7:K100-K105

Published in Volume 7 Supplement K, May 2011

A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods

• Poerner T,
• Otto S,
• Gassdorf J,
• Janiak F,
• Danzer C,
• Ferrari M,
• Figulla H

EuroIntervention 2011;7:K93-K99

Published in Volume 7 Supplement K, May 2011

A new paclitaxel-eluting balloon for angioplasty of femoropopliteal obstructions: acute and midterm results

• Micari A,
• Cioppa A,
• Stabile E,
• Castriota F,
• Pantaleo P,
• Grattoni C,
• Cremonesi A,
• Marchese A,
• Rubino P,
• Biamino G

EuroIntervention 2011;7:K77-K82

Published in Volume 7 Supplement K, May 2011

Coronary bifurcation lesions treated with the drug-eluting balloon: a preliminary insight from the DEBIUT study

• Belkacemi A,
• Agostoni P,
• Voskuil M,
• Stella P

EuroIntervention 2011;7:K66-K69

Published in Volume 7 Supplement K, May 2011

Treatment of bifurcation lesions with a drug-eluting balloon: the PEPCAD V (Paclitaxel Eluting PTCA Balloon in Coronary Artery Disease) trial

• Mathey D,
• Wendig I,
• Boxberger M,
• Bonaventura K,
• Kleber F-X

EuroIntervention 2011;7:K61-K65

Published in Volume 7 Supplement K, May 2011

In-stent restenosis: the gold standard has changed

• Chin K

EuroIntervention 2011;7:K43-K46

Published in Volume 7 Supplement K, May 2011